[go: up one dir, main page]

FI962506A0 - Psoriasiksen hoito - Google Patents

Psoriasiksen hoito

Info

Publication number
FI962506A0
FI962506A0 FI962506A FI962506A FI962506A0 FI 962506 A0 FI962506 A0 FI 962506A0 FI 962506 A FI962506 A FI 962506A FI 962506 A FI962506 A FI 962506A FI 962506 A0 FI962506 A0 FI 962506A0
Authority
FI
Finland
Prior art keywords
psoriasis
hyperkeratotic
management
pharmaceutical composition
dermatoses
Prior art date
Application number
FI962506A
Other languages
English (en)
Swedish (sv)
Other versions
FI117001B (fi
FI962506L (fi
Inventor
Joel A Sequeira
Imtiaz A Chaudry
Edwin A Peets
Daniel J Tanner
Eugene L Taylor
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI962506L publication Critical patent/FI962506L/fi
Publication of FI962506A0 publication Critical patent/FI962506A0/fi
Application granted granted Critical
Publication of FI117001B publication Critical patent/FI117001B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962506A 1993-12-21 1996-06-17 Menetelmä psoriasiksen hoitoon tehokas olevan farmaseuttisen seoksen valmistamiseksi FI117001B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17105193A 1993-12-21 1993-12-21
US17105193 1993-12-21
US9414165 1994-12-19
PCT/US1994/014165 WO1995017196A1 (en) 1993-12-21 1994-12-19 Psoriasis treatment

Publications (3)

Publication Number Publication Date
FI962506L FI962506L (fi) 1996-06-17
FI962506A0 true FI962506A0 (fi) 1996-06-17
FI117001B FI117001B (fi) 2006-05-15

Family

ID=22622295

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962506A FI117001B (fi) 1993-12-21 1996-06-17 Menetelmä psoriasiksen hoitoon tehokas olevan farmaseuttisen seoksen valmistamiseksi

Country Status (22)

Country Link
EP (1) EP0735885B1 (fi)
JP (2) JP3830963B2 (fi)
KR (1) KR100361240B1 (fi)
CN (1) CN1055392C (fi)
AT (1) ATE271896T1 (fi)
AU (1) AU701833B2 (fi)
CA (1) CA2179628C (fi)
CZ (1) CZ283932B6 (fi)
DE (1) DE69433923T2 (fi)
ES (1) ES2221928T3 (fi)
FI (1) FI117001B (fi)
HK (1) HK1008814A1 (fi)
HU (1) HU226621B1 (fi)
IL (1) IL112019A (fi)
MY (1) MY111719A (fi)
NO (1) NO310854B1 (fi)
NZ (1) NZ278198A (fi)
PL (1) PL178427B1 (fi)
SK (1) SK280766B6 (fi)
TW (1) TW442281B (fi)
WO (1) WO1995017196A1 (fi)
ZA (1) ZA9410143B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736265C2 (de) * 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen
WO2000012096A1 (fr) * 1998-08-26 2000-03-09 Shionogi & Co., Ltd. Pommades anti-inflammatoires
GR1006093B (el) * 2007-09-07 2008-10-06 Γεωργιος Καλλιμανης Παρασκευη φαρμακου με δραστικο συστατικο ουρσολικο οξυ (ursolic acid) για την θεραπεια ψωριασης
WO2010048675A1 (en) * 2008-10-30 2010-05-06 Ego Pharmaceuticals Pty Ltd Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
EP2394653A1 (en) 2010-05-26 2011-12-14 Almirall, S.A. Topical pharmaceutical compositions comprising mometasone furoate
CN114159453A (zh) * 2021-12-24 2022-03-11 广西馨海药业科技有限公司 白头翁皂苷b4在制备治疗或预防银屑病的药物的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579844A (en) * 1976-05-13 1986-04-01 Johnson & Johnson Topical anti-inflammatory drug therapy
DE2744826A1 (de) * 1976-10-06 1978-04-13 Marques Brev Soc Et Exploit Therapeutische zubereitung
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
YU46838B (sh) * 1986-02-14 1994-06-24 Pero Dr. Višnjić Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles

Also Published As

Publication number Publication date
AU1432895A (en) 1995-07-10
CN1138294A (zh) 1996-12-18
TW442281B (en) 2001-06-23
CA2179628A1 (en) 1995-06-29
NO962619D0 (no) 1996-06-20
JP2005139210A (ja) 2005-06-02
NZ278198A (en) 1997-12-19
IL112019A0 (en) 1995-03-15
HU9601708D0 (en) 1996-08-28
MY111719A (en) 2000-11-30
DE69433923T2 (de) 2005-07-21
ATE271896T1 (de) 2004-08-15
HUT74460A (en) 1996-12-30
AU701833B2 (en) 1999-02-04
PL315150A1 (en) 1996-10-14
ZA9410143B (en) 1995-06-20
FI117001B (fi) 2006-05-15
WO1995017196A1 (en) 1995-06-29
FI962506L (fi) 1996-06-17
JP3830963B2 (ja) 2006-10-11
JPH09506897A (ja) 1997-07-08
ES2221928T3 (es) 2005-01-16
CA2179628C (en) 2000-10-24
CN1055392C (zh) 2000-08-16
HU226621B1 (en) 2009-04-28
KR100361240B1 (ko) 2003-01-29
KR960706345A (ko) 1996-12-09
EP0735885B1 (en) 2004-07-28
NO310854B1 (no) 2001-09-10
PL178427B1 (pl) 2000-04-28
HK1008814A1 (en) 1999-05-21
EP0735885A1 (en) 1996-10-09
NO962619L (no) 1996-06-20
CZ283932B6 (cs) 1998-07-15
DE69433923D1 (de) 2004-09-02
IL112019A (en) 2000-02-17
SK81896A3 (en) 1997-04-09
SK280766B6 (sk) 2000-07-11
CZ178496A3 (en) 1997-04-16

Similar Documents

Publication Publication Date Title
FI973492A0 (fi) NO-syntaasin estäjät
AU2282395A (en) Nitric oxide donor composition and method for treatment of anal disorders
MY132705A (en) Novel compounds with analgesic effect
ATE229533T1 (de) Nitrat-salze als arzneimittel
DE69939720D1 (de) Fulvinsäure und deren Verwendung in der Behandlung von viralen Infektionen
PH31607A (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatosis.
AU6857887A (en) Therapeutic agent
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
MY127711A (en) Anti-vaginitis compositions for topical use
FI962506A0 (fi) Psoriasiksen hoito
ZA957506B (en) L-carnite salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ES8706027A1 (es) Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
DE69434002D1 (de) 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis
EP1061802A4 (en) TOPICAL CARBAMAZEPINE FORMULATIONS AND THEIR USE
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
IT1207990B (it) Attivita' analgesica, processo per derivati metil-piperazinici edla loro preparazione e composizioni terapeutiche che li contengono.
IT1270641B (it) Uso della midesteina come cicatrizzante e composizioni farmaceutiche topiche relative
ITMI930327A0 (it) Composizioni topiche per il trattamento dell'acne e delle dermatiti acneiformi

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117001

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: MERCK SHARP & DOHME CORP.

MA Patent expired